GO Term | Evidence Code | PMID |
---|---|---|
regulation of angiogenesis | ||
endocytosis | ||
positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction | ||
neutrophil chemotaxis |
|
|
mast cell degranulation |
|
GO Term | Evidence Code | PMID |
---|---|---|
kinase activity | ||
ephrin receptor binding | ||
1-phosphatidylinositol-3-kinase activity | ||
protein serine/threonine kinase activity | ||
protein serine kinase activity |
DO ID | Disease Name | Source |
---|---|---|
DOID:0050771 | pheochromocytoma | |
DOID:0050778 | Meckel syndrome | |
DOID:0050780 | obsolete Opitz-GBBB syndrome | |
DOID:0050782 | Zollinger-Ellison syndrome | |
DOID:0050787 | juvenile polyposis syndrome | |
DOID:0050819 | obsolete Matthew-Wood syndrome | |
DOID:0050848 | obstructive sleep apnea | |
DOID:0050865 | tongue squamous cell carcinoma | |
DOID:0050873 | follicular lymphoma | |
DOID:0050888 | syndromic intellectual disability |
HPO ID | HPO Term |
---|---|
HP:0000007 | Autosomal recessive inheritance |
HP:0000010 | Recurrent urinary tract infections |
HP:0000403 | Recurrent otitis media |
HP:0000964 | Eczematoid dermatitis |
HP:0001252 | Hypotonia |
HP:0001433 | Hepatosplenomegaly |
HP:0001581 | Recurrent skin infections |
HP:0001742 | Nasal congestion |
HP:0001744 | Splenomegaly |
HP:0001873 | Thrombocytopenia |
Disease ID | Disease Name |
---|---|
OMIM:619802 |
|
Species | Gene ID | Alliance of Genome Resources | Orthologous MAtrix |
---|---|---|---|
115180047 | SALTR55207 | ||
115198746 | SALTR65231 | ||
115542827 | GADMO46053 | ||
101173828 | ORYLA10866 | ||
100697462 | ORENI23913 | ||
108711184 | Xenbase:XB-GENE-17340298 | ||
108713077 | Xenbase:XB-GENE-6487000 | ||
100158519 | Xenbase:XB-GENE-1011009 | ||
101948128 | CHRPI21551 | ||
109315724 | CROPO05404 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024